| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 |
|---|
| Products | 231,521.00 | 245,138.00 | 226,616.00 | 203,738.00 | 190,688.00 | 185,236.00 | 183,910.00 | -- | -- | -- |
| Revenues | -- | -- | -- | -- | -- | -- | -- | 184,765.00 | 177,526.00 | 153,290.00 |
| Premiums | 122,896.00 | 99,192.00 | 85,330.00 | 76,132.00 | 69,364.00 | 63,122.00 | 8,184.00 | -- | -- | -- |
| Services | 16,239.00 | 12,293.00 | 9,683.00 | 11,042.00 | 7,856.00 | 7,407.00 | 1,825.00 | -- | -- | -- |
| Net investment income | 2,153.00 | 1,153.00 | 838.00 | 1,199.00 | 798.00 | 1,011.00 | 660.00 | -- | -- | -- |
| Total Revenues | 372,809.00 | 357,776.00 | 322,467.00 | 292,111.00 | 268,706.00 | 256,776.00 | 194,579.00 | 184,765.00 | 177,526.00 | 153,290.00 |
| Cost of revenues | 206,287.00 | 217,098.00 | 196,892.00 | 175,803.00 | 163,981.00 | 158,719.00 | 156,447.00 | 156,220.00 | 148,669.00 | 126,762.00 |
| Gross Profit | -- | -- | -- | 116,308.00 | 104,725.00 | 98,057.00 | 38,132.00 | 28,545.00 | 28,857.00 | 26,528.00 |
| Depreciation and amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Goodwill impairments | -- | 0.00 | -- | 431.00 | 0.00 | 0.00 | 6,149.00 | -- | -- | -- |
| Selling, general and administrative expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Restructuring charge | 1,179.00 | 507.00 | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on assets held for sale | 0.00 | (349.00) | (2,533.00) | -- | -- | -- | -- | -- | -- | -- |
| Operating income (expenses) | (41,606.00) | (39,832.00) | (38,212.00) | (37,066.00) | (35,135.00) | (33,541.00) | (21,368.00) | (19,028.00) | (18,519.00) | (17,074.00) |
| Benefit costs | -- | -- | (71,281.00) | (64,260.00) | (55,679.00) | (52,529.00) | (6,594.00) | -- | -- | -- |
| Store impairments | -- | 0.00 | -- | (1,358.00) | -- | -- | -- | -- | -- | -- |
| Opioid litigation charges | (100.00) | 0.00 | (5,803.00) | -- | -- | -- | -- | -- | -- | -- |
| Health care costs | (115,121.00) | (86,247.00) | -- | -- | -- | -- | -- | -- | -- | -- |
| Total operating costs | 364,293.00 | 344,033.00 | 314,721.00 | 278,918.00 | 254,795.00 | 244,789.00 | 190,558.00 | -- | -- | -- |
| Operating Income (Loss) | 8,516.00 | 13,743.00 | 7,746.00 | 13,193.00 | 13,911.00 | 11,987.00 | 4,021.00 | 9,517.00 | 10,338.00 | 9,454.00 |
| Interest expense, net | 2,958.00 | 2,658.00 | 2,287.00 | 2,503.00 | 2,907.00 | 3,035.00 | 2,619.00 | 1,041.00 | 1,058.00 | 838.00 |
| Loss on early extinguishment of debt | 491.00 | 0.00 | -- | (452.00) | (1,440.00) | (79.00) | 0.00 | 0.00 | (643.00) | 0.00 |
| Other expense | 99.00 | 88.00 | 169.00 | 182.00 | 206.00 | 124.00 | 4.00 | (208.00) | -- | -- |
| Income before income tax provision | 6,148.00 | 11,173.00 | 5,628.00 | 10,420.00 | 9,770.00 | 8,997.00 | 1,406.00 | 8,268.00 | 8,637.00 | 8,616.00 |
| Income tax (benefit) provision | 1,562.00 | 2,805.00 | 1,463.00 | 2,522.00 | 2,569.00 | 2,366.00 | 2,002.00 | 1,637.00 | 3,317.00 | 3,386.00 |
| Income (loss) from Continuing Operations | -- | -- | 4,165.00 | 7,898.00 | 7,201.00 | 6,631.00 | (596.00) | 6,631.00 | 5,320.00 | 5,230.00 |
| Income (Loss) from discontinued operations, net of tax benefit | -- | -- | -- | 0.00 | (9.00) | 0.00 | 0.00 | (8.00) | (1.00) | 9.00 |
| Consolidated Net Income (Loss) | 4,586.00 | 8,368.00 | 4,165.00 | 7,898.00 | 7,192.00 | 6,631.00 | (596.00) | 6,623.00 | 5,319.00 | 5,239.00 |
| Net loss attributable to noncontrolling interest | (28.00) | 24.00 | 16.00 | (12.00) | 13.00 | (3.00) | (2.00) | 1.00 | 2.00 | 2.00 |
| Preference dividends, net of income tax benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | 4,614.00 | 8,344.00 | 4,149.00 | 7,910.00 | 7,179.00 | 6,634.00 | (594.00) | 6,622.00 | 5,317.00 | 5,237.00 |
| Net earnings available to common shareholders, diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings from continuing operations (BASIC) | -- | -- | 3.16 | 6.00 | 5.49 | 5.10 | (0.57) | 6.48 | 4.93 | 4.65 |
| EPS (Basic) : Income (loss) from Discontinued operations | -- | -- | -- | -- | (0.01) | -- | 0.00 | (0.01) | 0.00 | 0.01 |
| Net Earnings Per Share (Basic) | 3.67 | 6.49 | 3.16 | 6.00 | 5.48 | 5.10 | (0.57) | 6.47 | 4.93 | 4.66 |
| Earnings from continuing operations (DILUTED) | -- | -- | 3.14 | 5.95 | 5.47 | 5.08 | (0.57) | 6.45 | 4.91 | 4.62 |
| EPS (Diluted) : Income (loss) from Discontinued operations | -- | -- | -- | -- | (0.01) | -- | 0.00 | (0.01) | 0.00 | 0.01 |
| Net Earnings Per Share (Diluted) | 3.66 | 6.47 | 3.14 | 5.95 | 5.46 | 5.08 | (0.57) | 6.44 | 4.90 | 4.63 |
| Weighted Average Shares Outstanding (Basic) | 1,259.00 | 1,285.00 | 1,312.00 | 1,319.00 | 1,309.00 | 1,301.00 | 1,044.00 | 1,020.00 | 1,073.00 | 1,118.00 |
| Weighted Average Shares Outstanding (Diluted) | 1,262.00 | 1,290.00 | 1,323.00 | 1,329.00 | 1,314.00 | 1,305.00 | 1,044.00 | 1,024.00 | 1,079.00 | 1,126.00 |